,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,3.19039365555694e-11,2.62250358486781e-08
2,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,1.24684033364966e-07,5.12451377130008e-05
3,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,9.55859818346799e-06,0.00207607063505576
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,1.02415558554602e-05,0.00207607063505576
5,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,1.26281668799012e-05,0.00207607063505576
6,WP_PROSTAGLANDIN_SIGNALING,22,Down,1.78766470969733e-05,0.00215093879863102
7,WP_IL26_SIGNALING,31,Down,1.98607042100798e-05,0.00215093879863102
8,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,29,Down,2.09337109355817e-05,0.00215093879863102
9,WP_HYPERTROPHY_MODEL,13,Down,3.94556829951318e-05,0.00360361904688871
10,WP_SPINAL_CORD_INJURY,66,Down,5.0882230263675e-05,0.00418251932767409
11,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,7.06639891596688e-05,0.00528052718993162
12,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,8.04381407676807e-05,0.00551001264258613
13,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,9.74475048758515e-05,0.00616168069291922
14,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.000115601243755809,0.00678744445480537
15,WP_MEVALONATE_PATHWAY,7,Down,0.000156504904714293,0.00820534041389348
16,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,78,Down,0.000159714655258267,0.00820534041389348
17,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.000196170137411385,0.00899481287558115
18,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.000196966705304697,0.00899481287558115
19,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.000251079877236879,0.0108625083730902
20,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.000279047377077056,0.011468847197867
21,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.000319835223728706,0.0120535101609409
22,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,76,Down,0.00032260002863832,0.0120535101609409
23,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.000343149414539046,0.0122638616848302
24,WP_GASTRIN_SIGNALING,94,Down,0.000397500198002555,0.0136143817815875
25,WP_CHEMOKINE_SIGNALING,109,Down,0.000458807867527211,0.0150856026842947
26,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.000504406990012569,0.0159470209919358
27,WP_PDGF_PATHWAY,37,Down,0.000548039423351453,0.0166847557775887
28,WP_IL1_SIGNALING,54,Down,0.000598085566490086,0.0175580834162447
29,WP_COMPLEMENT_ACTIVATION,12,Up,0.000757278901339546,0.0214649398931416
30,WP_TAMOXIFEN_METABOLISM,2,Up,0.000947928789692492,0.0257638446823658
31,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.00097162917901866,0.0257638446823658
32,WP_HEART_DEVELOPMENT,17,Down,0.00112591330452535,0.028921898009995
33,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Down,0.0011801210263843,0.0293202966572067
34,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.00121276166222023,0.0293202966572067
35,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.00144488875306465,0.0334005845721015
36,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Down,0.00146279932432561,0.0334005845721015
37,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.00174697775419304,0.0388112355120725
38,WP_ASPIRIN_AND_MIRNAS,8,Down,0.00200825988051427,0.0434418321521771
39,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Down,0.00221858328423731,0.0452437780211918
40,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.00223047391614293,0.0452437780211918
41,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,93,Down,0.00225668479181127,0.0452437780211918
42,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.00235342053845689,0.0458183410205793
43,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.0023968231920741,0.0458183410205793
44,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.00247425731114062,0.0462236252217635
45,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.00272025974075456,0.0495852874135294
46,WP_POSTCOVID_NEUROINFLAMMATION,12,Down,0.00277484576766709,0.0495852874135294
47,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.00298939859958729,0.0522826733800161
48,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.00311565288231127,0.0528018692948259
49,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.00318394902118863,0.0528018692948259
50,WP_NEUROINFLAMMATION,10,Down,0.00321179253618162,0.0528018692948259
51,WP_G13_SIGNALING,30,Down,0.00342945877129725,0.0552748060785557
52,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.0035783247277021,0.0565650562725217
53,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.00366396076571349,0.0568259575361602
54,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.00376409180375173,0.057297841901554
55,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,17,Down,0.00395783751845819,0.0591516807304115
56,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.00461524950116058,0.0677452694634642
57,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.00490576508423609,0.070746296477931
58,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.00513207535398806,0.0708983596683241
59,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.00518269404628405,0.0708983596683241
60,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.00522934949959589,0.0708983596683241
61,WP_VEGFAVEGFR2_SIGNALING,344,Down,0.00528994721095021,0.0708983596683241
62,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.005385237036646,0.0708983596683241
63,WP_FOCAL_ADHESION,121,Down,0.00543381588698834,0.0708983596683241
64,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.00556440447235477,0.0711740723093616
65,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Down,0.0056979885594489,0.0711740723093616
66,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.00578325046309326,0.0711740723093616
67,WP_MAPK_SIGNALING,165,Down,0.00580129299845161,0.0711740723093616
68,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.00619786095604094,0.0749212015568478
69,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.00635771669684485,0.0757397554319777
70,WP_AGERAGE_PATHWAY,54,Down,0.00654207637738543,0.0762405472051519
71,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.00658525407733064,0.0762405472051519
72,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.00670656862221601,0.0765666584369661
73,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.00686972199880945,0.0773549518222106
74,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.00743458542210662,0.0801108920874406
75,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.00758683178607371,0.0801108920874406
76,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.00766639165064589,0.0801108920874406
77,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.00771427463833583,0.0801108920874406
78,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.0077715187258888,0.0801108920874406
79,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Down,0.00777311559335671,0.0801108920874406
80,WP_HEPATITIS_B_INFECTION,119,Down,0.00794636576560446,0.0801108920874406
81,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.00799752395425258,0.0801108920874406
82,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.00807373980914468,0.0801108920874406
83,WP_EGFEGFR_SIGNALING,141,Down,0.00814712309787359,0.0801108920874406
84,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.00818651451988444,0.0801108920874406
85,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.00855564316850457,0.0827381021707148
86,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.00876555667155275,0.0837824137676321
87,WP_TNFALPHA_SIGNALING,85,Down,0.00930049999436217,0.0878736896019046
88,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.00947936857059898,0.088545920057186
89,WP_ERBB_SIGNALING,69,Down,0.0103262122417238,0.095372432165134
90,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.0106181012722135,0.0969786582862167
91,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.0110763719498328,0.100048457847432
92,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.0111976376179608,0.100048457847432
93,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0114852307660576,0.101287239331097
94,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0115827256655999,0.101287239331097
95,WP_NOTCH_SIGNALING_WP268,35,Down,0.012168568964414,0.10265829136544
96,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.0123320513904643,0.10265829136544
97,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,73,Down,0.0124317704110573,0.10265829136544
98,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0125816621881543,0.10265829136544
99,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.0126594272832642,0.10265829136544
100,WP_CCL18_SIGNALING,21,Down,0.0127629670531753,0.10265829136544
101,WP_SPHINGOLIPID_PATHWAY,20,Down,0.0128222395284551,0.10265829136544
102,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.0128361178093277,0.10265829136544
103,WP_NEPHROTIC_SYNDROME,27,Down,0.0128635085287595,0.10265829136544
104,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,89,Down,0.0130876619828399,0.103442866825907
105,WP_PDGFRBETA_PATHWAY,28,Down,0.013830659519442,0.108274305952203
106,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.0139859074342919,0.108456753877245
107,WP_SYNAPTIC_VESICLE_PATHWAY,22,Down,0.0142367656563353,0.109370293172969
108,WP_CREATINE_PATHWAY,2,Down,0.0146710385811487,0.110540517350633
109,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.0146872783082988,0.110540517350633
110,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0147925266527611,0.110540517350633
111,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.0152300696080985,0.112784839800513
112,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,0.0159578393650717,0.117119142482937
113,WP_CHOLESTEROL_METABOLISM,54,Down,0.0161190169498292,0.11725514984743
114,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.0163943539471484,0.118211920566281
115,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0170667593213748,0.121990227497131
116,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.0175958166786058,0.124645425799359
117,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.0177415022123175,0.124645425799359
118,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.0182984477912681,0.127468848173071
119,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0189489722585987,0.130514070660711
120,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.0190531490015637,0.130514070660711
121,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.0192131798089082,0.130522593412583
122,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.0199734422881663,0.134575160335022
123,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.0206555784892636,0.137628207270098
124,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.0207614327268761,0.137628207270098
125,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0209404836581801,0.137704620536193
126,WP_BURN_WOUND_HEALING,61,Down,0.0217194048341354,0.140672329082793
127,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0217340459775118,0.140672329082793
128,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.0223546340543216,0.143247940502918
129,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0225327729759127,0.143247940502918
130,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.0226547837778337,0.143247940502918
131,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.0231806694676735,0.145454277117768
132,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.0233711534672121,0.145538546591275
133,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.0237261188063997,0.145949860999371
134,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.0238713145528367,0.145949860999371
135,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0239698676823785,0.145949860999371
136,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0242615818580692,0.146571596779505
137,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0244285994632509,0.146571596779505
138,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.0246376235329325,0.146754540174424
139,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0260196873391837,0.153871820092151
140,WP_WNT_SIGNALING_WP363,38,Down,0.0263731866822134,0.154848281805567
141,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.0271956646455275,0.157932097546683
142,WP_PLEURAL_MESOTHELIOMA,256,Down,0.0272826737854368,0.157932097546683
143,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.0283187491450277,0.162783299281208
144,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,9,Up,0.0288589231929964,0.164736353226688
145,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0291067456791005,0.165005137573935
146,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.0300197178887824,0.16815760569049
147,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.0300719805796862,0.16815760569049
148,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.031152616750399,0.173023317356946
149,WP_GLUTATHIONE_METABOLISM,11,Down,0.0320910337087113,0.17703912556081
150,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.0334447841097037,0.183277416921176
151,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.0338563627552078,0.184304173409144
152,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.0344623689071982,0.186368863432348
153,WP_CAMKK2_PATHWAY,30,Down,0.037237672708966,0.19813164444916
154,WP_NETRINUNC5B_SIGNALING,35,Down,0.0375859339470967,0.19813164444916
155,WP_THERMOGENESIS,74,Down,0.0377096963935015,0.19813164444916
156,WP_VITAMIN_D_RECEPTOR_PATHWAY,86,Down,0.0379942175636048,0.19813164444916
157,WP_INSULIN_SIGNALING,132,Down,0.0380304781367827,0.19813164444916
158,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Up,0.0380869697762053,0.19813164444916
159,WP_AXON_GUIDANCE,38,Down,0.0383247341452755,0.19813164444916
160,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.0387725600124177,0.199050220859196
161,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.0389867220904265,0.199050220859196
162,WP_TGFB_SMAD_SIGNALING,7,Down,0.0397782160081845,0.201837614560047
163,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0414151957010011,0.208854545191552
164,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,87,Down,0.0421668560021291,0.211348509961891
165,WP_LUNG_FIBROSIS,33,Down,0.0425173602225194,0.211760275550274
166,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.0427642405612475,0.211760275550274
167,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,48,Down,0.0443223785878132,0.216865386815715
168,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.0445372983498651,0.216865386815715
169,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.0445866792844961,0.216865386815715
170,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,5,Down,0.0449121598158712,0.217163502168507
171,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.0460206724116768,0.221222179663148
172,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0471208760757243,0.223683560183101
173,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0472751930006673,0.223683560183101
174,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.0473490747832841,0.223683560183101
175,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0479742521349116,0.225341915742271
176,WP_SEROTONIN_AND_ANXIETY,8,Down,0.0483889710197065,0.225804275884897
177,WP_MAPK_CASCADE,30,Down,0.0486220886029523,0.225804275884897
178,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.0495091277220454,0.227645121370749
179,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0495723561135817,0.227645121370749
180,WP_OREXIN_RECEPTOR_PATHWAY,118,Down,0.0502715053621289,0.229573207820389
181,WP_IL3_SIGNALING,46,Down,0.0511812446113817,0.230711804137965
182,WP_GABA_RECEPTOR_SIGNALING,10,Down,0.0513586016374159,0.230711804137965
183,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,9,Down,0.0513628469066273,0.230711804137965
184,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.0517121249279219,0.231018297232347
185,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.0520467868164968,0.231256533854921
186,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0530347576772316,0.233790237064199
187,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.0531858568503713,0.233790237064199
188,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.0539448251879885,0.23398217650492
189,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.0541105813664013,0.23398217650492
190,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.0541752834805943,0.23398217650492
191,WP_OVARIAN_INFERTILITY,22,Down,0.0543681213046712,0.23398217650492
192,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.0578348148515325,0.247134270744634
193,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.0580254431310395,0.247134270744634
194,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.0601235198693608,0.253661521912164
195,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,19,Down,0.0601751785558052,0.253661521912164
196,WP_PURINERGIC_SIGNALING,16,Down,0.0613127529910919,0.255952767256971
197,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,137,Down,0.0613414782842134,0.255952767256971
198,WP_WNT_SIGNALING_WP428,60,Down,0.0621503116709257,0.257413437017438
199,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.062317851540718,0.257413437017438
200,WP_DNA_REPLICATION,36,Up,0.0674356781781276,0.274609417067122
201,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.0677481783664605,0.274609417067122
202,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.0679632830914454,0.274609417067122
203,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.0679849527551867,0.274609417067122
204,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.0682015623730171,0.274609417067122
205,WP_RAS_SIGNALING,119,Down,0.0687672351484818,0.274609417067122
206,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0689197861134593,0.274609417067122
207,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0691534663417204,0.274609417067122
208,WP_GPCRS_CLASS_B_SECRETINLIKE,5,Down,0.0698243444176432,0.275940438035109
209,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.070641866824896,0.276869110345386
210,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.0707329843948066,0.276869110345386
211,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.0714781146248725,0.278459764083627
212,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.0739957477055275,0.286320217709445
213,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.0741960402421946,0.286320217709445
214,WP_GPCRS_OTHER,15,Down,0.0745407866056219,0.286320217709445
215,WP_RANKLRANK_SIGNALING,48,Down,0.0758988991849477,0.290180907581521
216,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.0775133828700989,0.29498148481121
217,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.0782326963479752,0.296346895843482
218,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.0792451228933373,0.298805004671208
219,WP_MONOAMINE_GPCRS,3,Down,0.0802758396539618,0.30035557408434
220,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.0803871366162468,0.30035557408434
221,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0815723502183175,0.30340485013329
222,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.0829130323447848,0.307002308952311
223,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.0834365006633005,0.307555172848579
224,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.0838967838084632,0.307871233439986
225,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0844033840726052,0.308353696478584
226,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.0850647796780443,0.309394906616604
227,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.085597210671395,0.309429200580462
228,WP_ARYLAMINE_METABOLISM,1,Up,0.0858270775332667,0.309429200580462
229,WP_IL19_SIGNALING,20,Down,0.0866036378134754,0.309835993092305
230,WP_IL18_SIGNALING,192,Down,0.0866937693567276,0.309835993092305
231,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.0872634190447392,0.310521776860501
232,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.0890038635598708,0.314774040794086
233,WP_IRINOTECAN_PATHWAY,5,Up,0.0893903762265,0.314774040794086
234,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.089607208693207,0.314774040794086
235,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.0901693896677006,0.315401014071702
236,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.0913020113127815,0.318007524163146
237,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.0918053962045789,0.318007524163146
238,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.0920751712297186,0.318007524163146
239,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.0928781061996398,0.319438507515079
240,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.0939646585193164,0.320896853611168
241,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0940828974699409,0.320896853611168
242,WP_MONOAMINE_TRANSPORT,12,Down,0.0951153882837887,0.321632910183959
243,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.0954600153298117,0.321632910183959
244,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.095472542682343,0.321632910183959
245,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.0972738498957994,0.325151452853567
246,WP_LEPTIN_SIGNALING,70,Down,0.0973080990291696,0.325151452853567
247,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.0977399614852237,0.325272260489287
248,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.098782787667512,0.326579219144548
249,WP_SELENIUM_MICRONUTRIENT_NETWORK,51,Down,0.09926156976576,0.326579219144548
250,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0996220350471026,0.326579219144548
251,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.099721878351924,0.326579219144548
252,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.100493594716416,0.327800535146403
253,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.101158040263797,0.328663672319529
254,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.102154773523977,0.330595369435863
255,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.104172552209881,0.335803285947145
256,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.10523803539217,0.337912754267045
257,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.106262990525998,0.339876179814671
258,WP_16P112_DISTAL_DELETION_SYNDROME,22,Up,0.108992804651834,0.346970690433574
259,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.109325314868973,0.346970690433574
260,WP_BENZENE_METABOLISM,4,Up,0.110705638169183,0.348491267856414
261,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.110984454266373,0.348491267856414
262,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.11107659946823,0.348491267856414
263,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.111678532965493,0.348491267856414
264,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.111924202815199,0.348491267856414
265,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.113434200558729,0.350031574298579
266,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.113552314682166,0.350031574298579
267,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.113743976864619,0.350031574298579
268,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.114122216437979,0.350031574298579
269,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,74,Down,0.115383713294308,0.351271597870643
270,WP_BENZOAPYRENE_METABOLISM,5,Up,0.115467591767496,0.351271597870643
271,WP_LUNG_PATHOLOGY_OF_COVID19,15,Down,0.115808519492633,0.351271597870643
272,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Down,0.116747281152545,0.351900309963064
273,WP_SLEEP_REGULATION,11,Up,0.117068966137034,0.351900309963064
274,WP_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.117728205887886,0.351900309963064
275,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.117728205887886,0.351900309963064
276,WP_NPHP1_DELETION_SYNDROME,10,Down,0.121401590343223,0.361565606022206
277,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.123762310884553,0.367253447305744
278,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.124204937166663,0.367253447305744
279,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.125090945663621,0.367973900598855
280,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,177,Down,0.125699960217879,0.367973900598855
281,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,14,Down,0.126183631002698,0.367973900598855
282,WP_PROLACTIN_SIGNALING,69,Down,0.12659535605408,0.367973900598855
283,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.12668687818671,0.367973900598855
284,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,169,Down,0.129731614745657,0.37549080042581
285,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.131178255896547,0.378345706480567
286,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.136096611255437,0.390465306553404
287,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.136562209704326,0.390465306553404
288,WP_NOTCH_SIGNALING_WP61,49,Down,0.136805362880025,0.390465306553404
289,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.139706664701363,0.397366361192113
290,WP_CANCER_PATHWAYS,311,Down,0.14025849307454,0.397560280369902
291,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.141922971990567,0.400719824413297
292,WP_OSTEOCLAST_SIGNALING,9,Down,0.142348161470417,0.400719824413297
293,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.144523171788311,0.405454086040926
294,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,74,Down,0.145448232537303,0.406452708684271
295,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Down,0.145868064552141,0.406452708684271
296,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.146663311092099,0.407287978776031
297,WP_PURINE_METABOLISM,10,Down,0.148214339329779,0.410209383599591
298,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.149437896727814,0.412207889631755
299,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.152975026272081,0.420553416707863
300,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.154978903129904,0.423680937100069
301,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.156111863418257,0.423680937100069
302,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.15622326082948,0.423680937100069
303,WP_ATR_SIGNALING,10,Up,0.156610548973428,0.423680937100069
304,WP_BLADDER_CANCER,29,Down,0.157063032093837,0.423680937100069
305,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.157763570189883,0.423680937100069
306,WP_UROTENSINIIMEDIATED_SIGNALING,49,Down,0.158127838021363,0.423680937100069
307,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.158281659069124,0.423680937100069
308,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.159084050452902,0.423680937100069
309,WP_OSTEOBLAST_SIGNALING,3,Down,0.159826766328803,0.423680937100069
310,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.160007846213387,0.423680937100069
311,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.160297775472167,0.423680937100069
312,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.165224446146833,0.434133753343098
313,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.165493188202295,0.434133753343098
314,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.165836981204055,0.434133753343098
315,WP_ENDOMETRIAL_CANCER,49,Down,0.166930588051128,0.435609344057228
316,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.168164117862635,0.437439572414829
317,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.17054431810102,0.441838852459135
318,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.170930358980541,0.441838852459135
319,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.174598497725637,0.449905846803993
320,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.175760447590104,0.450866768212141
321,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.176068409484303,0.450866768212141
322,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.177957320957392,0.454288564680052
323,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.179545506206886,0.456253235941581
324,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.179837041903981,0.456253235941581
325,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.183062076229529,0.461789194571681
326,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.183142673272954,0.461789194571681
327,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Down,0.184802406701353,0.464435768481323
328,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.185725935154777,0.464435768481323
329,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.185887308796053,0.464435768481323
330,WP_TGFBETA_RECEPTOR_SIGNALING,36,Down,0.186640087554845,0.464903490818431
331,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.187776399472854,0.466320847029262
332,WP_DRAVET_SYNDROME,15,Down,0.188490470777438,0.466684237888718
333,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.190544388086594,0.467621720948571
334,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.191289385058023,0.467621720948571
335,WP_ANGIOGENESIS,14,Down,0.191983648189852,0.467621720948571
336,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.19208788772386,0.467621720948571
337,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.192306674957357,0.467621720948571
338,WP_RETT_SYNDROME,33,Down,0.192784677887948,0.467621720948571
339,WP_PRION_DISEASE_PATHWAY,28,Down,0.19285129367587,0.467621720948571
340,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.193710364856397,0.468323293858701
341,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.194924740716165,0.469877234219025
342,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.196471668914418,0.469946691316736
343,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.19731628070332,0.469946691316736
344,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.197487371749679,0.469946691316736
345,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.197812110943541,0.469946691316736
346,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.197812110943541,0.469946691316736
347,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.199344552655857,0.472222542602636
348,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.200095535685363,0.472639454980945
349,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,22,Down,0.201127815228711,0.473716516097423
350,WP_FRAGILE_X_SYNDROME,84,Down,0.202234194320734,0.474961450661837
351,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.203039484841598,0.475494178176049
352,WP_HIPPOYAP_SIGNALING,16,Down,0.203702858511098,0.475692470727622
353,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.20490146081494,0.477135979574734
354,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.206810706024212,0.480221469920629
355,WP_MELANOMA,54,Down,0.207776714946204,0.480267614861082
356,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.207999113005529,0.480267614861082
357,WP_BDNFTRKB_SIGNALING,27,Down,0.209154256845863,0.481582070384592
358,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.2098304896709,0.481789560082346
359,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.213353993187197,0.487633388673416
360,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.213581865719506,0.487633388673416
361,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.214155295998909,0.487633388673416
362,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.219253145221395,0.496740777992293
363,WP_FERROPTOSIS,51,Down,0.219684981946544,0.496740777992293
364,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.220322715915661,0.496740777992293
365,WP_HUNGER_AND_SATIETY,2,Up,0.220572243269084,0.496740777992293
366,WP_G_PROTEIN_SIGNALING,62,Down,0.221402991787184,0.49724934221056
367,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.222154999953946,0.49757877373881
368,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.223044475208164,0.497587581898888
369,WP_CYTOSINE_METHYLATION,7,Down,0.223682033139034,0.497587581898888
370,WP_NAD_METABOLISM,12,Down,0.223974945623587,0.497587581898888
371,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.225369694809715,0.498266180817621
372,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,31,Down,0.225492724165639,0.498266180817621
373,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.226447413841835,0.498620483537122
374,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.227374580434308,0.498620483537122
375,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.227472848328979,0.498620483537122
376,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Down,0.230132558937052,0.501797005795743
377,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.230142908984179,0.501797005795743
378,WP_ENDODERM_DIFFERENTIATION,84,Down,0.234406581036984,0.505433818272654
379,WP_BASE_EXCISION_REPAIR,29,Up,0.235367939829439,0.505433818272654
380,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.236015546645465,0.505433818272654
381,WP_IDO_METABOLIC_PATHWAY,7,Down,0.236373821809526,0.505433818272654
382,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.236723656042086,0.505433818272654
383,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.236823664272911,0.505433818272654
384,WP_HISTONE_MODIFICATIONS,37,Up,0.237054006738616,0.505433818272654
385,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.237099664159922,0.505433818272654
386,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.237344834371344,0.505433818272654
387,WP_DNA_MISMATCH_REPAIR,21,Up,0.239757025061493,0.509251355556969
388,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.242417264587819,0.511548005199425
389,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Down,0.242430359783266,0.511548005199425
390,WP_AFLATOXIN_B1_METABOLISM,3,Up,0.242705257941333,0.511548005199425
391,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.243456223125747,0.511818453732389
392,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Down,0.244195280737243,0.512062552974525
393,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.248023854016034,0.518767450384683
394,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.249213128223935,0.51993195786821
395,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.251367755296187,0.521113814528521
396,WP_PREIMPLANTATION_EMBRYO,21,Down,0.251788827006481,0.521113814528521
397,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.251996337288091,0.521113814528521
398,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.252577621352628,0.521113814528521
399,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.252949406322238,0.521113814528521
400,WP_SMALL_CELL_LUNG_CANCER,69,Down,0.253715823565148,0.521386017426379
401,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.255738080523053,0.524231177531045
402,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.258293596574619,0.52815257807049
403,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.259738502382118,0.529789203369978
404,WP_ADIPOGENESIS,86,Down,0.2618274524223,0.532728133393888
405,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.265669172612474,0.539210024413467
406,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.267359429990237,0.540331295697709
407,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.267536298478063,0.540331295697709
408,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,38,Down,0.268592155260797,0.541134195157782
409,WP_IL5_SIGNALING,37,Down,0.272184713437618,0.54643453382049
410,WP_LIPID_PARTICLES_COMPOSITION,6,Up,0.272666642583266,0.54643453382049
411,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.273658850718196,0.54643453382049
412,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.273882029116839,0.54643453382049
413,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.276430397880537,0.550183503771917
414,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.278813183174042,0.55310465442571
415,WP_FOXP3_IN_COVID19,9,Down,0.279243834047043,0.55310465442571
416,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.280227621803916,0.553719002699085
417,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.281737671938046,0.554063102497373
418,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,278,Down,0.281851896213855,0.554063102497373
419,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.282423892878831,0.554063102497373
420,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.283626016703186,0.555096632690521
421,WP_IL4_SIGNALING,51,Down,0.28546265869179,0.556554113940536
422,WP_NUCLEAR_RECEPTORS,20,Down,0.285724861414728,0.556554113940536
423,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.289230864975133,0.562051468107705
424,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.290813783262867,0.563794645853954
425,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Down,0.292267434867336,0.56527960343753
426,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.293379339989399,0.566098163078136
427,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.294726463410594,0.567365697713133
428,WP_KREBS_CYCLE_DISORDERS,12,Up,0.298955450430379,0.574162103396662
429,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.305569584985499,0.582141493522956
430,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Down,0.305686793036408,0.582141493522956
431,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Down,0.305900299059294,0.582141493522956
432,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.306024346284024,0.582141493522956
433,WP_IL7_SIGNALING,23,Down,0.30681694719296,0.582141493522956
434,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.307359377358836,0.582141493522956
435,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.308423945349974,0.582814903626847
436,WP_WNT_SIGNALING_AND_PLURIPOTENCY,61,Down,0.310154665139738,0.584124298430119
437,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.310538100260294,0.584124298430119
438,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.312195704960948,0.585755999776201
439,WP_ENERGY_METABOLISM,41,Down,0.312830759004565,0.585755999776201
440,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.314066399574364,0.586733137386653
441,WP_AUTOPHAGY,27,Down,0.31540906936111,0.587905340169689
442,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.317264306457423,0.589749214458643
443,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.317844161606412,0.589749214458643
444,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.3185506705835,0.589749214458643
445,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.321346639446163,0.593588623875834
446,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.322235674458228,0.593896243059784
447,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,23,Up,0.328256122164896,0.603638774987796
448,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.329363055166122,0.604322391398555
449,WP_GLYOXYLATE_METABOLISM,5,Up,0.332113325182902,0.606685925572578
450,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.332850366000632,0.606685925572578
451,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.332865392254541,0.606685925572578
452,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Up,0.333833503885305,0.607104292463985
453,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.341212673103532,0.619154122055416
454,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.342114465437366,0.619423107025364
455,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.345917384860164,0.624932066714407
456,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.348708025964972,0.627568951336623
457,WP_G1_TO_S_CELL_CYCLE_CONTROL,51,Up,0.348903906035081,0.627568951336623
458,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.351042599543335,0.629500172232979
459,WP_ESTROGEN_METABOLISM_WP697,6,Up,0.352544827376347,0.629500172232979
460,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.352819371136275,0.629500172232979
461,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.353040850850856,0.629500172232979
462,WP_VITAMIN_B12_DISORDERS,9,Down,0.356599870361577,0.631947493753863
463,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.357032028734358,0.631947493753863
464,WP_P38_MAPK_SIGNALING,31,Down,0.357392218389112,0.631947493753863
465,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.357488545736674,0.631947493753863
466,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.362595958917226,0.639600597059999
467,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Down,0.366865291149233,0.644156471780892
468,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.366928260883167,0.644156471780892
469,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.367529665772796,0.644156471780892
470,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.370630911641167,0.647440314213203
471,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.370982186926233,0.647440314213203
472,WP_METASTATIC_BRAIN_TUMOR,5,Down,0.371766214487387,0.647440314213203
473,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.375898407280069,0.65277419206881
474,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.37795268243001,0.65277419206881
475,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.378356611402856,0.65277419206881
476,WP_IL2_SIGNALING,37,Down,0.378420225184857,0.65277419206881
477,WP_PI3KAKT_SIGNALING,180,Down,0.378799622404894,0.65277419206881
478,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Down,0.380562534370938,0.654440174169269
479,WP_VITAMIN_D_METABOLISM,6,Down,0.381800410286592,0.655198198863421
480,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.383061141293656,0.655992204465386
481,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.385494007468071,0.658772328679879
482,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.386287423873116,0.658772328679879
483,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.387214837668709,0.658973259762446
484,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.388008586040175,0.658973259762446
485,WP_BREAST_CANCER_PATHWAY,87,Down,0.390286506008028,0.661475274100205
486,WP_RETINOL_METABOLISM,6,Down,0.393516050125325,0.664467277356388
487,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.393668569431339,0.664467277356388
488,WP_SPINA_BIFIDA,10,Up,0.394808591559794,0.665025947258505
489,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.396542825486658,0.66658119130886
490,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.39803356984065,0.667136260332424
491,WP_SMALL_LIGAND_GPCRS,7,Down,0.399224023383523,0.667136260332424
492,WP_ALANINE_AND_ASPARTATE_METABOLISM,6,Down,0.399621976556839,0.667136260332424
493,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.400169735925525,0.667136260332424
494,WP_ALLOGRAFT_REJECTION,51,Down,0.401130829690478,0.667136260332424
495,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.40174263852135,0.667136260332424
496,WP_JOUBERT_SYNDROME,72,Up,0.410527881731036,0.680173519664698
497,WP_TAR_SYNDROME,44,Down,0.412627523367922,0.680173519664698
498,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.413701799190722,0.680173519664698
499,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.415996684219225,0.680173519664698
500,WP_COMPLEMENT_SYSTEM,52,Up,0.416362224187708,0.680173519664698
501,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.416526187929676,0.680173519664698
502,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.416823588735515,0.680173519664698
503,WP_DOPAMINE_METABOLISM,7,Up,0.416902141896879,0.680173519664698
504,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.417452557488314,0.680173519664698
505,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.418538541348529,0.680173519664698
506,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.418695621594084,0.680173519664698
507,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.425424244142979,0.689741082219977
508,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.427780505433669,0.691225620180796
509,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.429080737642429,0.691225620180796
510,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.429599021166431,0.691225620180796
511,WP_NUCLEAR_RECEPTORS_METAPATHWAY,180,Down,0.42970351814159,0.691225620180796
512,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.432493969028705,0.69205145662255
513,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.432589723986865,0.69205145662255
514,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.432742638326022,0.69205145662255
515,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.43475794100253,0.693924325250639
516,WP_BLOOD_CLOTTING_CASCADE,6,Down,0.438595691835767,0.698693136994187
517,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.444000284328059,0.705934688041904
518,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.445135796011257,0.706373792125971
519,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Down,0.44817180236218,0.707902795916123
520,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.448494986023556,0.707902795916123
521,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,29,Down,0.44954388291404,0.707902795916123
522,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,29,Down,0.450136073948133,0.707902795916123
523,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.450405306890672,0.707902795916123
524,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Down,0.452273433532563,0.709482370923219
525,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.45615943935741,0.71019848638823
526,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.456242321721298,0.71019848638823
527,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.456287229750877,0.71019848638823
528,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,11,Up,0.456694520488941,0.71019848638823
529,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.457530813064677,0.71019848638823
530,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.457913865919418,0.71019848638823
531,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.45883103207006,0.710280806707324
532,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,4,Up,0.460574747278639,0.710922291695418
533,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.461335532526084,0.710922291695418
534,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.461840028911622,0.710922291695418
535,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Down,0.464572806524639,0.712595029785888
536,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.465507736131768,0.712595029785888
537,WP_ECTODERM_DIFFERENTIATION,78,Down,0.465566062506443,0.712595029785888
538,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.466844232660055,0.712595029785888
539,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.467261217827973,0.712595029785888
540,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Up,0.469378690947331,0.714498673997603
541,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.472863762643281,0.718473221613266
542,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.474249887449885,0.719249829305914
543,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.480367589304114,0.727186295410647
544,WP_GLUCURONIDATION,7,Up,0.481556050111709,0.727256952148983
545,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Down,0.482183745646223,0.727256952148983
546,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,17,Up,0.487233979546042,0.733528079096788
547,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.488908997886519,0.734704197920876
548,WP_TCELL_ACTIVATION_SARSCOV2,63,Down,0.490384732492595,0.735577098738892
549,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.492668477170088,0.735976371014874
550,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Up,0.494196048131528,0.735976371014874
551,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,12,Up,0.494774299053367,0.735976371014874
552,WP_CORI_CYCLE,12,Down,0.495408662313758,0.735976371014874
553,WP_CILIOPATHIES,129,Up,0.495932834101223,0.735976371014874
554,WP_IL11_SIGNALING,41,Down,0.497371797269392,0.735976371014874
555,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.497705461531534,0.735976371014874
556,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.497848721941688,0.735976371014874
557,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.498984906219614,0.735976371014874
558,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.500136115143776,0.735976371014874
559,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.500801525250923,0.735976371014874
560,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.501395094608673,0.735976371014874
561,WP_RETINOBLASTOMA_GENE_IN_CANCER,74,Up,0.504996000828058,0.739433270432201
562,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.506307107882691,0.739433270432201
563,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.507087842805171,0.739433270432201
564,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.507782943961613,0.739433270432201
565,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.508247929190017,0.739433270432201
566,WP_ALZHEIMERS_DISEASE,185,Down,0.510408944435068,0.73995794060957
567,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,185,Down,0.510408944435068,0.73995794060957
568,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.512575665366359,0.741790839667512
569,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.514234859483035,0.74288410280326
570,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.520108333076831,0.750050964542378
571,WP_PROTEASOME_DEGRADATION,57,Down,0.521740299405917,0.75102666198792
572,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.522612227076752,0.75102666198792
573,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.525897499210258,0.753791294585754
574,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.526574578881179,0.753791294585754
575,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.527966065521546,0.753791294585754
576,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.529641243956298,0.753791294585754
577,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.530822348133852,0.753791294585754
578,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.531526238711111,0.753791294585754
579,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.531872202992381,0.753791294585754
580,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.531872202992381,0.753791294585754
581,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.538020404832144,0.760391427452019
582,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.539114685036747,0.760391427452019
583,WP_IL6_SIGNALING,38,Down,0.540355116215163,0.760391427452019
584,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.541892988455377,0.760391427452019
585,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.542265729999548,0.760391427452019
586,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.54264082793847,0.760391427452019
587,WP_KALLMANN_SYNDROME,11,Down,0.543655315038547,0.760391427452019
588,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.5453889550831,0.760391427452019
589,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.5457304543724,0.760391427452019
590,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.54701427457214,0.760391427452019
591,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.547629835829192,0.760391427452019
592,WP_HEME_BIOSYNTHESIS,8,Up,0.547629835829192,0.760391427452019
593,WP_METHYLATION_PATHWAYS,5,Up,0.551384790704224,0.764314161819345
594,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.552865094038366,0.765075938214708
595,WP_OSTEOPONTIN_SIGNALING,11,Down,0.555005475559031,0.766747060352141
596,WP_AMINO_ACID_METABOLISM,59,Up,0.558531792908462,0.770324049950932
597,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.561680235191656,0.773368766042783
598,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Up,0.564565716223153,0.774012532177647
599,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.564825156822418,0.774012532177647
600,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.566072735179972,0.774012532177647
601,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.566803683810873,0.774012532177647
602,WP_NUCLEOTIDE_GPCRS,6,Down,0.567656323191624,0.774012532177647
603,WP_ONECARBON_METABOLISM,23,Up,0.568030443491878,0.774012532177647
604,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.569796162168742,0.774012532177647
605,WP_ACUTE_VIRAL_MYOCARDITIS,65,Down,0.57005282493467,0.774012532177647
606,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.570622377736806,0.774012532177647
607,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.574541346701281,0.776946572810818
608,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.574675810546201,0.776946572810818
609,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Down,0.580438230712463,0.783448646380368
610,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Up,0.58167736059631,0.783834082639618
611,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.583156887120032,0.784541671379159
612,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.584729888282168,0.785372497006441
613,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.588527223285786,0.78918332388404
614,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Down,0.590602067557132,0.789797854253158
615,WP_VITAMIN_B12_METABOLISM,25,Down,0.590926779878738,0.789797854253158
616,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.591867978369763,0.789797854253158
617,WP_NEPHROGENESIS,4,Up,0.595743894462873,0.791490697915784
618,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Down,0.59853207363637,0.791490697915784
619,WP_ID_SIGNALING,12,Down,0.599644745753004,0.791490697915784
620,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.600962531638541,0.791490697915784
621,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.602229540338679,0.791490697915784
622,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.602524881727538,0.791490697915784
623,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.603358149088155,0.791490697915784
624,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.603859906216585,0.791490697915784
625,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.604180145660479,0.791490697915784
626,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.604915541376997,0.791490697915784
627,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.607944366973181,0.791490697915784
628,WP_TRANSSULFURATION_PATHWAY,8,Up,0.608495224986247,0.791490697915784
629,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.611367772299808,0.791490697915784
630,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.612143939576709,0.791490697915784
631,WP_IRON_METABOLISM_DISORDERS,10,Up,0.612317740729244,0.791490697915784
632,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.612485920337888,0.791490697915784
633,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.612803357375673,0.791490697915784
634,WP_GPR40_PATHWAY,10,Down,0.613131016541385,0.791490697915784
635,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.614025132863571,0.791490697915784
636,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.614442697848504,0.791490697915784
637,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.614442697848504,0.791490697915784
638,WP_FLUOROPYRIMIDINE_ACTIVITY,26,Down,0.615757121788936,0.791490697915784
639,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.615959382430783,0.791490697915784
640,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.616245798863871,0.791490697915784
641,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.620302261661669,0.795457814486571
642,WP_MRNA_PROCESSING,124,Down,0.623191484854137,0.79791806939268
643,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.625618752828639,0.799780116368804
644,WP_DNA_DAMAGE_RESPONSE,58,Up,0.632200555751668,0.806790253465162
645,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.633065344872298,0.806790253465162
646,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.634055030669775,0.806800673700549
647,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.637338786893277,0.808764873919626
648,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.638103156221485,0.808764873919626
649,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.640963085665902,0.808764873919626
650,WP_COPPER_HOMEOSTASIS,40,Down,0.640983531345074,0.808764873919626
651,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.641721692461624,0.808764873919626
652,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,22,Up,0.641831628565518,0.808764873919626
653,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.642882141482378,0.808764873919626
654,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.643469863191528,0.808764873919626
655,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,59,Up,0.647710542436409,0.811657035206215
656,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.647745760456541,0.811657035206215
657,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.649759633117827,0.812941276138286
658,WP_SERINE_METABOLISM,7,Up,0.653803457812601,0.815405753934611
659,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.654417247616141,0.815405753934611
660,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.654705349874505,0.815405753934611
661,WP_KLEEFSTRA_SYNDROME,25,Down,0.659152208500911,0.819702141282524
662,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Up,0.661579199239198,0.821477495127826
663,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.664396163505741,0.823730990047841
664,WP_CILIARY_LANDSCAPE,186,Down,0.667260551555944,0.826036405691244
665,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Down,0.670889905130287,0.829280454161046
666,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.675145779298278,0.833288033908686
667,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,15,Up,0.676337760622788,0.8335077049954
668,WP_AEROBIC_GLYCOLYSIS,10,Up,0.680792836044216,0.837742082677164
669,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.683103154511637,0.839328539624164
670,WP_CIRCADIAN_RHYTHM_GENES,122,Down,0.689615204487659,0.844651308384452
671,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.690517857949333,0.844651308384452
672,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.690517857949333,0.844651308384452
673,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.693435186198842,0.846959469621765
674,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.699049690554554,0.852234979406767
675,WP_PRIMARY_OVARIAN_INSUFFICIENCY,90,Up,0.699998740266286,0.852234979406767
676,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Down,0.700864776251794,0.852234979406767
677,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.706290413381546,0.856890164652683
678,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Down,0.707219432729876,0.856890164652683
679,WP_CELLULAR_PROTEOSTASIS,6,Up,0.708809387295475,0.856890164652683
680,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.70886290993166,0.856890164652683
681,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Up,0.71379885167539,0.861195202693635
682,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.714821631022924,0.861195202693635
683,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.717305543669938,0.861195202693635
684,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Down,0.71930658799377,0.861195202693635
685,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.72280263875865,0.861195202693635
686,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.723605911319519,0.861195202693635
687,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.725146293332279,0.861195202693635
688,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Up,0.72590129002928,0.861195202693635
689,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.726709863271816,0.861195202693635
690,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.726715504896442,0.861195202693635
691,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.727820937234927,0.861195202693635
692,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.728589832682845,0.861195202693635
693,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.729150827643187,0.861195202693635
694,WP_NRXN1_DELETION_SYNDROME,2,Up,0.729803904097499,0.861195202693635
695,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.73072539685569,0.861195202693635
696,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.730781021794712,0.861195202693635
697,WP_CHOLESTASIS,9,Up,0.731994056412753,0.861195202693635
698,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.733167290099027,0.861195202693635
699,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.733633585752049,0.861195202693635
700,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.734529097431045,0.861195202693635
701,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,18,Up,0.735180522526034,0.861195202693635
702,WP_MATRIX_METALLOPROTEINASES,8,Down,0.735473275293104,0.861195202693635
703,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.741297776022368,0.866780614353324
704,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.742852800233829,0.867365059363931
705,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.744795869941325,0.867895037941915
706,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.746216391268119,0.867895037941915
707,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.746474199300406,0.867895037941915
708,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.750627776924403,0.871420993742479
709,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.753037619624942,0.871420993742479
710,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.753501370117079,0.871420993742479
711,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.753747355901341,0.871420993742479
712,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Down,0.756387865369801,0.872758806615635
713,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.757028015957358,0.872758806615635
714,WP_MALE_INFERTILITY,71,Up,0.763090238089756,0.878515652254593
715,WP_PPARALPHA_PATHWAY,15,Up,0.769068709129286,0.882082050047732
716,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.769320044820332,0.882082050047732
717,WP_MIRNA_BIOGENESIS,6,Up,0.769407335625576,0.882082050047732
718,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.772807867651977,0.883648257914964
719,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.773108744214585,0.883648257914964
720,WP_KININKALLIKREIN_PATHWAY,2,Down,0.7739984740861,0.883648257914964
721,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.779930069522466,0.889185183283588
722,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Down,0.782350067197143,0.890708802266
723,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Up,0.783786889084501,0.891110405017233
724,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.788431946305077,0.895153397600515
725,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.79089536805078,0.89671171384516
726,WP_ZINC_HOMEOSTASIS,22,Up,0.794457344484329,0.899509555325232
727,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.798809398062229,0.903193019542162
728,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.802435470510315,0.904594521470823
729,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.802955541696344,0.904594521470823
730,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.803350365783091,0.904594521470823
731,WP_MTHFR_DEFICIENCY,18,Down,0.80621984064781,0.906583733259234
732,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,41,Down,0.80740619504885,0.906677448538463
733,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.811144763601854,0.907446839915946
734,WP_CELL_CYCLE,96,Up,0.812404119090506,0.907446839915946
735,WP_ENDOTHELIN_PATHWAYS,12,Down,0.812452186594538,0.907446839915946
736,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.813605531653144,0.907446839915946
737,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.813611096129017,0.907446839915946
738,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.815182016601421,0.907966961580444
739,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.820990426018776,0.912080196421888
740,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.821094094102429,0.912080196421888
741,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.82476625900077,0.912938672277761
742,WP_IL9_SIGNALING,15,Down,0.825153265385139,0.912938672277761
743,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.82590454329176,0.912938672277761
744,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.831400454860775,0.912938672277761
745,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.831815346859941,0.912938672277761
746,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.831890883420346,0.912938672277761
747,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.833916802299031,0.912938672277761
748,WP_PPAR_SIGNALING,39,Up,0.834175771632056,0.912938672277761
749,WP_NRF2ARE_REGULATION,20,Up,0.83454552982532,0.912938672277761
750,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.834560458639387,0.912938672277761
751,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.834748100752306,0.912938672277761
752,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Up,0.835194503105689,0.912938672277761
753,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.84548250083499,0.922956992943375
754,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.847158489112563,0.923449936519594
755,WP_STEROID_BIOSYNTHESIS,3,Up,0.849452767211693,0.923449936519594
756,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.850182653120202,0.923449936519594
757,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,42,Down,0.850427739592862,0.923449936519594
758,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.853406513219244,0.924512363995157
759,WP_5Q35_COPY_NUMBER_VARIATION,78,Down,0.85365557697363,0.924512363995157
760,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,20,Up,0.858288877502699,0.928307180667393
761,WP_METABOLIC_EPILEPTIC_DISORDERS,61,Down,0.865212791100809,0.933717873524645
762,WP_MEASLES_VIRUS_INFECTION,101,Down,0.866435090635805,0.933717873524645
763,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.867744690044236,0.933717873524645
764,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.868165584468258,0.933717873524645
765,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.868971013681695,0.933717873524645
766,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.872240926914958,0.936007887629367
767,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.877899427676442,0.940851798631076
768,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.890572012424777,0.951847430686097
769,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.890820124184849,0.951847430686097
770,WP_PYRIMIDINE_METABOLISM,73,Down,0.891633237990626,0.951847430686097
771,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.894799082252963,0.953585073282663
772,WP_VALPROIC_ACID_PATHWAY,9,Down,0.89558111505379,0.953585073282663
773,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.897068121398592,0.953932724178063
774,WP_TP53_NETWORK,16,Down,0.905145578297953,0.960564446232866
775,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.906180888592612,0.960564446232866
776,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.907419583806418,0.960564446232866
777,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.908507389329393,0.960564446232866
778,WP_ATM_SIGNALING,34,Up,0.910016999254105,0.960564446232866
779,WP_ESTROGEN_SIGNALING,21,Down,0.91031594113796,0.960564446232866
780,WP_APOPTOSIS,73,Up,0.9142515107604,0.963480438262883
781,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.915829013766868,0.963907105398676
782,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.919924094714306,0.963938814047844
783,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.921908412369046,0.963938814047844
784,WP_FOXA2_PATHWAY,10,Up,0.922207461354746,0.963938814047844
785,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.923600480364477,0.963938814047844
786,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Up,0.924025846375805,0.963938814047844
787,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.924343151282672,0.963938814047844
788,WP_BARDETBIEDL_SYNDROME,65,Up,0.925916996024586,0.963938814047844
789,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.926516578513941,0.963938814047844
790,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Down,0.92814813531412,0.963938814047844
791,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.929561080910458,0.963938814047844
792,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.930610074734907,0.963938814047844
793,WP_EICOSANOID_SYNTHESIS,14,Up,0.93210392562741,0.963938814047844
794,WP_TRANSLATION_FACTORS,49,Down,0.932217172023105,0.963938814047844
795,WP_TRYPTOPHAN_METABOLISM,18,Up,0.935209517583751,0.963938814047844
796,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.935428846632987,0.963938814047844
797,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.935627383812734,0.963938814047844
798,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.936266619910663,0.963938814047844
799,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.936967290053805,0.963938814047844
800,WP_IL17_SIGNALING,25,Up,0.938755138985186,0.964570905307279
801,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.94896981027989,0.973849168601835
802,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.957994857845522,0.981885003926458
803,WP_MACROPHAGE_MARKERS,8,Down,0.95963521046341,0.982341398506753
804,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.964193460723069,0.985779881485526
805,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.96779765912321,0.987819580489315
806,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Up,0.969547337758987,0.987819580489315
807,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.96979367573586,0.987819580489315
808,WP_FOLATE_METABOLISM,38,Down,0.97188025183098,0.988719761144883
809,WP_SILDENAFIL_TREATMENT,11,Up,0.97831328339544,0.994034016008716
810,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.98352381005658,0.99809453316853
811,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.98618691225826,0.998537097227675
812,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.98638944397673,0.998537097227675
813,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.988324348447841,0.999120248468764
814,WP_ALSTROM_SYNDROME,27,Up,0.99336842998085,0.999120248468764
815,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.993656453523558,0.999120248468764
816,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.994936197876026,0.999120248468764
817,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,11,Down,0.996318855002762,0.999120248468764
818,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.997063829456216,0.999120248468764
819,WP_NRF2_PATHWAY,74,Up,0.998182062458218,0.999120248468764
820,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.998330729078926,0.999120248468764
821,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.998537478071575,0.999120248468764
822,WP_PEPTIDE_GPCRS,14,Up,0.999120248468764,0.999120248468764
